The present study provides evidence for CPTP as a biomarker and candidate therapeutic target of PC; however, further investigation is required into the suppression of metastasis by targeting CPTP and increased patient survival in follow-up studies. The gene discussed is CPTP; the disease is pachyonychia congenita.